Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis

BACKGROUND: Tegoprazan is a novel potassium‐competitive acid blocker used to treat acid‐related disorders. AIM: To compare tegoprazan 25 mg with lansoprazole 15 mg as maintenance therapy in healed erosive oesophagitis (EE) METHODS: In this phase 3, double‐blind, multi‐centre study, patients with end...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yu Kyung, Kim, Jae Hak, Kim, Hyun‐Soo, Kim, Tae‐Oh, Oh, Jung‐Hwan, Choi, Suck Chei, Moon, Jeong Seop, Lee, Sang Kil, Jung, Sung Woo, Kim, Sung Soo, Jung, Hye‐Kyung, Lee, Sang Pyo, Cheon, Gab‐Jin, Park, Moo In, Jung, Hwoon‐Yong, Ko, Kwang Hyun, Sung, In Kyung, Lee, Si Hyung, Lee, Ju Yup, Lee, Soo Teik, Rhee, Poong‐Lyul, Kim, Nayoung, Hong, Su Jin, Kim, Hyun Jin, Kim, Gwang Ha, Lee, Kwang Jae, Kim, Sung Kook, Shin, Woon Geon, Lee, Oh Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092320/
https://www.ncbi.nlm.nih.gov/pubmed/36314172
http://dx.doi.org/10.1111/apt.17255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092320/
https://www.ncbi.nlm.nih.gov/pubmed/36314172
http://dx.doi.org/10.1111/apt.17255

Ejemplares similares